A2093

Image

1 of 1

A2093

Sigma

 

Aspirin

meets USP testing specifications

Synonym:2-Acetoxybenzoic acid, O-Acetylsalicylic acid, Acetylsalicylic acid, ASA, Aspirin
CAS Number:50-78-2
Linear Formula:2-(CH3CO2)C6H4CO2H
Molecular Weight:180.16
Beilstein Registry Number:779271
EC Number:200-064-1
MDL number:MFCD00002430
PubChem Substance ID:24890623

Related Products

Reviews

Description

Features and BenefitsBlocks the production of prostaglandins by inhibiting cyclooxygenase (prostaglandin H synthase), with greater selectivity toward the COX-1 isoform. The antithrombotic effect is due to the inhibition of COX-1 in platelets that blocks thromboxane production and platelet aggregation. Chemopreventive against colorectal and other solid tumors.

Properties

mp134-136 °C(lit.)
suitabilitymeets USP testing specifications
Gene Informationhuman ... ITGA2B(3674), PTGS1(5742), PTGS2(5743)

Safety

Personal Protective Equipmentdust mask type N95 (US), Eyeshields, Faceshields, Gloves
Hazard CodesXn
Risk Statements22-36/37/38
Safety Statements26
WGK Germany1
RTECSVO0700000
Flash Point(F)482 °F
Flash Point(C)250 °C

References

referenceGilroy, D. W., Differential effects of inhibition of isoforms of cyclooxygenase (COX-1 and COX-2) in chronic inflammation. Inflamm. Res. 47, 79, (1998)
 Gilroy, D. W., et al., Differential effects of inhibitors of cyclooxygenase (COX-1 and COX-2) in acute inflammation. Eur. J. Pharmacol. 355, 211-217, (1998)
 Schror, K., Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis. Semin. Thromb. Hemost. 23, 349-356, (1997)
 Shiff, S.J., et al., Cyclooxygenase inhibitors: drugs for cancer prevention. Curr. Opin. Pharmacol. 3, 352-361, (2003)
MerckMerck 13,856
BeilsteinBeil. 10,IV,138
 Aldrich MSDS 1, 26:B / Corp MSDS 1 (1), 48:C / FT-IR 1 (2), 315:D / FT-IR 2 (2), 2887:B / FT-NMR 1 (2), 1293:B / IR-Spectra (2), 909:F / IR-Spectra (3), 1040:A / NMR-Reference 2 (2), 303:D / RegBook 1 (2), 1929:K / Sax 6, 88 / Sigma FT-IR 1 (1), 610:B / Structure Index 1, 310:C:4